Evaluation of fracture risk and fracture prevention: an Italian picture.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3476518)

Published in Clin Cases Miner Bone Metab on September 30, 2012

Authors

Maria Luisa Brandi1

Author Affiliations

1: Mineral and Bone Metabolism Unit, Department of Internal Medicine, University Hospital of Careggi, Florence, Italy.

Articles cited by this

Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res (2000) 7.29

A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 6.85

Risk of new vertebral fracture in the year following a fracture. JAMA (2001) 6.17

The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone (1995) 5.76

Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum (2006) 2.73

Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int (2004) 2.62

The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study. Osteoporos Int (2003) 2.22

The osteoporosis care gap in Canada. BMC Musculoskelet Disord (2004) 1.81

Fracture outcomes related to persistence and compliance with oral bisphosphonates. J Bone Miner Res (2008) 1.78

Mortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (1998) 1.76

Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study. Osteoporos Int (2003) 1.74

Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey. Osteoporos Int (2006) 1.54

Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: a long-term prospective study. J Bone Miner Res (2005) 1.51

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int (2011) 1.50

Hip fractures in Italy: 2000-2005 extension study. Osteoporos Int (2009) 1.36

Proximal humeral fracture as a risk factor for subsequent hip fractures. J Bone Joint Surg Am (2009) 1.28

The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study. Arthritis Res Ther (2010) 1.17

Epidemiology of fragility fractures in Italy. Clin Cases Miner Bone Metab (2011) 1.10

Antifracture efficacy of currently available therapies for postmenopausal osteoporosis. Drugs (2011) 1.08

25 hydroxyvitamin D serum levels influence adequate response to bisphosphonate treatment in postmenopausal osteoporosis. Bone (2012) 1.01

A reappraisal of generic bisphosphonates in osteoporosis. Osteoporos Int (2011) 0.98

Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression. Osteoporos Int (2011) 0.93

Contralateral hip fractures and other osteoporosis-related fractures in hip fracture patients: incidence and risk factors. An observational cohort study of 1,229 patients. Arch Orthop Trauma Surg (2012) 0.93

Updated fracture incidence rates for the Italian version of FRAX®. Osteoporos Int (2012) 0.92

Community based intervention to optimize osteoporosis management: randomized controlled trial. BMC Geriatr (2010) 0.91

The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis. Expert Rev Pharmacoecon Outcomes Res (2012) 0.89

Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club. Osteoporos Int (2011) 0.89

Cost-effectiveness of a fixed dose combination of alendronate and cholecalciferol in the treatment and prevention of osteoporosis in the United Kingdom and The Netherlands. Curr Med Res Opin (2008) 0.89

Randomized trial of alendronate plus vitamin D3 versus standard care in osteoporotic postmenopausal women with vitamin D insufficiency. Calcif Tissue Int (2011) 0.88

Antifracture drugs consumption in Tuscany Region before the Target Project: a valuable model for the analysis of administrative database. Clin Cases Miner Bone Metab (2012) 0.85

Compliance to antifracture treatments in Tuscany: a regional survey based on institutional pharmaceutical dataset. Clin Cases Miner Bone Metab (2011) 0.82